» Articles » PMID: 8141787

The Region Around Residue 115 of Human Bactericidal/permeability-increasing Protein is Not Involved in Lipopolysaccharide Binding or Bactericidal Activity. Chemical Synthesis and Expression of a Gene Coding for the Active Domain and Characterization...

Overview
Journal Biochem J
Specialty Biochemistry
Date 1994 Mar 15
PMID 8141787
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Bactericidal/permeability-increasing protein (BPI) is a potent antimicrobial agent produced by polymorphonuclear leucocytes that specifically interacts with and kills Gram-negative bacteria. An 825 bp gene determining the bactericidal N-terminal domain of human BPI was chemically synthesized and expressed as inclusion bodies in Escherichia coli. The recombinant polypeptide, BPI', was solubilized and conditions under which it folded to give the active protein were determined. Folding was critically dependent on the urea and salt concentrations as well as the pH. BPI' bound with high affinity to Salmonella typhimurium cells (apparent Kd = 36 nM), permeabilized their outer membranes to actinomycin D, specifically activated a synovial fluid phospholipase A2 and showed potent bactericidal activity. In contrast with the native protein, however, it could not be efficiently released from the cell surface by the addition of high concentrations of Mg2+ ions. Pre-incubation of the protein with lipopolysaccharide or trypsin prevented cytotoxicity. However, boiling BPI' immediately before its addition to cells did not block its bactericidal activity, suggesting that it may be able to function even when presented to cells in an unfolded form. A BPI' derivative, containing a 13-residue foreign antigenic determinant genetically inserted between Ala115 and Asp116, was also produced. The derivative was functional in the above assays and bound with high affinity to S. typhimurium (apparent Kd = 74 nM). These results imply that the region defined by these residues is not involved in the lipopolysaccharide-binding or bactericidal activities of BPI. The availability of functional, nonglycosylated recombinant derivatives of BPI should greatly aid detailed studies on its structure, interactions with lipopolysaccharide and mechanism of action.

Citing Articles

Bactericidal permeability increasing protein gene variants in children with sepsis.

Michalek J, Svetlikova P, Fedora M, Klimovic M, Klapacova L, Bartosova D Intensive Care Med. 2007; 33(12):2158-64.

PMID: 17898994 DOI: 10.1007/s00134-007-0860-3.


Enhanced hydrolysis of phosphatidylcholine by human group II non-pancreatic secreted phospholipase A2 as a result of interfacial activation by specific anions. Potential role of cholesterol sulphate.

Kinkaid A, Wilton D Biochem J. 1995; 308 ( Pt 2):507-12.

PMID: 7772034 PMC: 1136954. DOI: 10.1042/bj3080507.

References
1.
Weiss J, Wright G, Bekkers A, Van den Bergh C, Verheij H . Conversion of pig pancreas phospholipase A2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein. J Biol Chem. 1991; 266(7):4162-7. View

2.
Nikaido H, Vaara M . Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985; 49(1):1-32. PMC: 373015. DOI: 10.1128/mr.49.1.1-32.1985. View

3.
Mannion B, Kalatzis E, Weiss J, Elsbach P . Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. Implications and use as a means of purification. J Immunol. 1989; 142(8):2807-12. View

4.
APPLEYARD R . Segregation of New Lysogenic Types during Growth of a Doubly Lysogenic Strain Derived from Escherichia Coli K12. Genetics. 1954; 39(4):440-52. PMC: 1209664. DOI: 10.1093/genetics/39.4.440. View

5.
Jayaraman K, Shah J, Fyles J . PCR mediated gene synthesis. Nucleic Acids Res. 1989; 17(11):4403. PMC: 317973. DOI: 10.1093/nar/17.11.4403. View